<DOC>
	<DOC>NCT01995786</DOC>
	<brief_summary>The aim of the study is to evaluate clinical and economic impact of Goal Directed Fluid Therapy according to NICE haemodynamic protocol. Haemodynamic parameters were assessed using automated pulse contour analysis (Flotrac/Vigileo®). A specific dedicated software has been developed to perform clinical and expenditures data collection, both retrospective and prospective data are archived.</brief_summary>
	<brief_title>Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>Patients selected for major abdominal surgery •Patients under the age of 18, patients with hemodynamically significant aortic regurgitation and heart rhythm disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Fluid Therapy</keyword>
	<keyword>Cost-Benefit Analysis</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Cost Control</keyword>
</DOC>